Vical VICL Swine Flu H1N1 Vaccine Promising

Shares of Vical Inc. (VICL) are surging this morning ( 6/30/09 ) because they company is out with some promising data for their swine flu vaccine. Discuss VICL

Discuss Stocks - http://stockstobuy.org

Vical Inc. ( VICL ) Stock News - June 30, 2009

Vical H1 Influenza Vaccine Delivers Robust Preclinical Results With 100% Response

June 30, 2009 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company's vaccine against A/H1N1 pandemic influenza (swine flu) produced robust immune responses well above the accepted protection threshold in 100% of vaccinated mice and rabbits after a standard two-dose vaccine regimen. In addition, at least 75% of vaccinated animals achieved or exceeded the protection threshold after a single dose of vaccine. The company is ready to advance directly to large-scale cGMP manufacturing of the vaccine for human clinical trials, subject to securing external funding for this program.

"Our DNA vaccine technology offers an innovative approach to dealing with pandemics," said Vijay B. Samant, President and Chief Executive Officer of Vical. "The speed of our platform both in development and manufacturing was demonstrated by our rapid completion of vaccine production and successful immunogenicity testing in animals while conventional vaccine manufacturers are still working toward production of their initial supply of H1 vaccine. We are encouraged by these compelling data with our Vaxfectin(r)-formulated DNA vaccine and we look forward to advancing to human clinical trials as soon as possible."

Full Article

For More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE